- Home
- BTMD vs IRWD Comparison
BTMD vs IRWD Comparison
Compare BTMD & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTMD
- IRWD
- Stock Information
- Founded
- BTMD 2012
- IRWD 1998
- Country
- BTMD United States
- IRWD United States
- Employees
- BTMD N/A
- IRWD N/A
- Industry
- BTMD Medicinal Chemicals and Botanical Products
- IRWD Biotechnology: Pharmaceutical Preparations
- Sector
- BTMD Health Care
- IRWD Health Care
- Exchange
- BTMD Nasdaq
- IRWD Nasdaq
- Market Cap
- BTMD 127.8M
- IRWD 111.2M
- IPO Year
- BTMD N/A
- IRWD 2010
- Fundamental
- Price
- BTMD $3.33
- IRWD $1.28
- Analyst Decision
- BTMD Buy
- IRWD Buy
- Analyst Count
- BTMD 2
- IRWD 5
- Target Price
- BTMD $6.00
- IRWD $4.94
- AVG Volume (30 Days)
- BTMD 146.9K
- IRWD 1.2M
- Earning Date
- BTMD 11-11-2025
- IRWD 11-06-2025
- Dividend Yield
- BTMD N/A
- IRWD N/A
- EPS Growth
- BTMD 642.53
- IRWD N/A
- EPS
- BTMD 0.88
- IRWD N/A
- Revenue
- BTMD $199,073,000.00
- IRWD $308,519,000.00
- Revenue This Year
- BTMD N/A
- IRWD N/A
- Revenue Next Year
- BTMD $4.85
- IRWD N/A
- P/E Ratio
- BTMD $3.82
- IRWD N/A
- Revenue Growth
- BTMD 6.32
- IRWD N/A
- 52 Week Low
- BTMD $2.76
- IRWD $0.53
- 52 Week High
- BTMD $6.98
- IRWD $5.13
- Technical
- Relative Strength Index (RSI)
- BTMD 46.42
- IRWD 60.43
- Support Level
- BTMD $3.27
- IRWD $1.05
- Resistance Level
- BTMD $3.52
- IRWD $1.35
- Average True Range (ATR)
- BTMD 0.16
- IRWD 0.09
- MACD
- BTMD 0.02
- IRWD -0.01
- Stochastic Oscillator
- BTMD 18.31
- IRWD 75.00
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.